Calmark is granted design protection for the single-use item in the EU and the US

14 January 2020 - 17:29

The World Intellectual Property Organization (WIPO) has announced that Calmark Sweden AB has been granted registration of the design in the EU and the US for the company’s unique single-use item.

Calmark's product Neo, which consists of a reader and single-use tests for point-of-care diagnostics of important medical conditions in newborns, has a unique industrial design that the company has worked a long time to develop. The single-use item is designed with a focus on technical function and ease of use. As Calmark Sweden AB is planning a global launch, the company is working actively with both patents and design rights in important future markets. The application and approval in the EU and the US are important parts of the strategy.

"The design protection of the single-use item is very important for our upcoming product launch,” says CEO Anna Söderlund. "Protecting the intangible values that we have built up in the company for more than ten years is an obvious focus for Calmark."


Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

For more information about Calmark Sweden AB, please contact:

Anna Söderlund, CEO
Telefon: +46 70 213 25 35
E-post: anna.soderlund@calmark.se 
www.calmark.se 

Calmark Sweden AB is a medical technology company developing a point-of-care (POC) analyzis method with easier and faster sampling of medical conditions in newborns. The unique test platform, which consists of a reader and single-use products, is expected to be ready for launch in 2020 when three important POC tests are introduced. The WHO estimates that 1.5 billion children will be born worldwide by 2030. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter healthcare chains. In less developed healthcare systems, the product helps save lives. Calmark aims to become the global leader and ultimately to offer all relevant POC tests for the first period of life, regardless of where in the world a baby is born. Read more about Calmark www.calmark.se/eng/home.  

Provided by: Cision

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More